Indian pharmaceutical companies may replace Western manufacturers leaving the Russian market, Russian envoy to India Denis Alipov said on Friday.
"The withdrawal of many Western companies from the Russian market and those niches that have been vacated may actually be occupied by Indian companies in many industries, in particular, in pharmaceuticals," Alipov told the Rossiya 24 broadcaster, as quoted by Sputnik news agency.
The newly appointed Russian envoy added that India is a "world pharmacy" and a leading manufacturer of drug copies that are no worse than the original.
India's Vaccine Maitri initiative last year reinforced its credentials as the "pharmacy of the world". World leaders publicly commended India's efforts to rapidly expand vaccines production and supplies at critical junctures of the pandemic.
This decision to replace manufacturers in pharmaceutical comes at a time when Russia has been bombarded with sanctions from Western countries. Now Russia is looking to enhance economic engagement with countries non-European countries.
Earlier this month, Alipov had said that Moscow has welcomed the independent foreign policy of India amid the Russia-Ukraine conflict.
Touching upon the relations with India, Alipov said, "Prime Minister (Modi) and the Indian leadership meet the consistent independent policy of the state in international affairs. We have repeatedly stated that we have welcomed the independent foreign policy of India and strengthening its role and its influence in the international arena."
The Russian envoy also hailed the Indian foreign policy stand on the ongoing Russia-Ukraine conflict.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU